Venkat Lakshmi Kishan Vuddanda, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Appendage | 8 | 2019 | 278 | 1.320 |
Why?
|
| Octreotide | 1 | 2017 | 154 | 0.540 |
Why?
|
| Atrial Fibrillation | 7 | 2019 | 5031 | 0.540 |
Why?
|
| Insurance Claim Review | 1 | 2019 | 741 | 0.480 |
Why?
|
| Arteriovenous Malformations | 1 | 2017 | 396 | 0.470 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2019 | 3621 | 0.360 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 1116 | 0.350 |
Why?
|
| Catheter Ablation | 5 | 2018 | 2634 | 0.300 |
Why?
|
| Patient Readmission | 1 | 2019 | 3269 | 0.250 |
Why?
|
| Tachycardia, Ventricular | 3 | 2018 | 1261 | 0.250 |
Why?
|
| Stroke | 5 | 2019 | 9712 | 0.240 |
Why?
|
| Defibrillators, Implantable | 2 | 2018 | 1483 | 0.150 |
Why?
|
| Alloys | 1 | 2018 | 110 | 0.150 |
Why?
|
| Injections, Subcutaneous | 1 | 2017 | 671 | 0.130 |
Why?
|
| Septal Occluder Device | 1 | 2017 | 125 | 0.130 |
Why?
|
| Atrioventricular Block | 1 | 2017 | 132 | 0.130 |
Why?
|
| Heart Atria | 2 | 2019 | 1333 | 0.130 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2017 | 451 | 0.110 |
Why?
|
| Postoperative Complications | 4 | 2019 | 15612 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2017 | 510 | 0.100 |
Why?
|
| Colectomy | 1 | 2017 | 686 | 0.100 |
Why?
|
| Esophagus | 1 | 2018 | 1031 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 1 | 2018 | 941 | 0.100 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 39063 | 0.100 |
Why?
|
| Myocarditis | 1 | 2019 | 788 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2019 | 5293 | 0.090 |
Why?
|
| Survival Rate | 3 | 2019 | 12719 | 0.090 |
Why?
|
| Heart-Assist Devices | 2 | 2018 | 1288 | 0.090 |
Why?
|
| Primary Prevention | 1 | 2018 | 1185 | 0.090 |
Why?
|
| Coronary Angiography | 2 | 2019 | 4470 | 0.090 |
Why?
|
| Exercise Test | 1 | 2017 | 2127 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2019 | 2595 | 0.080 |
Why?
|
| Heart Diseases | 2 | 2018 | 2778 | 0.080 |
Why?
|
| Heart Transplantation | 2 | 2018 | 3232 | 0.070 |
Why?
|
| Treatment Outcome | 9 | 2019 | 64568 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2018 | 6346 | 0.070 |
Why?
|
| Atrial Function, Left | 2 | 2019 | 183 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2017 | 4160 | 0.070 |
Why?
|
| Inpatients | 1 | 2018 | 2544 | 0.070 |
Why?
|
| Biopsy | 1 | 2018 | 6762 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 1948 | 0.070 |
Why?
|
| Myocardium | 1 | 2018 | 4724 | 0.060 |
Why?
|
| Aged | 10 | 2019 | 169042 | 0.060 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 2190 | 0.060 |
Why?
|
| Registries | 2 | 2018 | 8207 | 0.060 |
Why?
|
| Incidence | 2 | 2019 | 21337 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2019 | 80566 | 0.050 |
Why?
|
| Male | 13 | 2019 | 360358 | 0.050 |
Why?
|
| United States | 6 | 2019 | 72272 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2018 | 23972 | 0.050 |
Why?
|
| Echocardiography | 3 | 2019 | 4987 | 0.050 |
Why?
|
| Female | 12 | 2019 | 392148 | 0.050 |
Why?
|
| Exercise | 1 | 2017 | 5886 | 0.040 |
Why?
|
| Action Potentials | 2 | 2017 | 1825 | 0.040 |
Why?
|
| Hospitalization | 1 | 2019 | 10704 | 0.040 |
Why?
|
| Humans | 17 | 2019 | 760617 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2019 | 7960 | 0.040 |
Why?
|
| Hypertension | 1 | 2018 | 8529 | 0.040 |
Why?
|
| Middle Aged | 8 | 2019 | 220584 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 6403 | 0.040 |
Why?
|
| Systole | 1 | 2018 | 935 | 0.030 |
Why?
|
| Time Factors | 4 | 2018 | 39913 | 0.030 |
Why?
|
| Heart Rate | 2 | 2017 | 4180 | 0.030 |
Why?
|
| Magnesium | 1 | 2018 | 804 | 0.030 |
Why?
|
| Body Temperature | 1 | 2018 | 780 | 0.030 |
Why?
|
| Recurrence | 2 | 2017 | 8426 | 0.030 |
Why?
|
| Electric Countershock | 1 | 2017 | 532 | 0.030 |
Why?
|
| Syncope | 1 | 2017 | 428 | 0.030 |
Why?
|
| Potassium | 1 | 2018 | 1311 | 0.030 |
Why?
|
| Logistic Models | 2 | 2019 | 13245 | 0.030 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2017 | 480 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 1155 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2278 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2017 | 763 | 0.030 |
Why?
|
| Sodium | 1 | 2018 | 1588 | 0.030 |
Why?
|
| Creatinine | 1 | 2018 | 1896 | 0.030 |
Why?
|
| Pulmonary Veins | 1 | 2018 | 716 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 1085 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2018 | 10199 | 0.020 |
Why?
|
| Europe | 1 | 2017 | 3413 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 1269 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2017 | 2114 | 0.020 |
Why?
|
| Equipment Design | 1 | 2017 | 3501 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1661 | 0.020 |
Why?
|
| Young Adult | 3 | 2019 | 59179 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 2234 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2018 | 2110 | 0.020 |
Why?
|
| Risk Factors | 3 | 2018 | 74115 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5239 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12043 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10548 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 3873 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2018 | 54360 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2017 | 5486 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10505 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15251 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2017 | 4785 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 220969 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 26180 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29600 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 58894 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 88234 | 0.010 |
Why?
|